PLAU and urothelial carcinoma: Third, CK2α knockdown with CK2α-siRNA fully eliminates uPA activity in UMUC2 cells and reduces uPA activity by half in a human urothelial carcinoma cell line, UMUC6, generated by long-term culture in doxorubicin [62].